BRIDGEBIO PHARMA INC. - COMMON STOCK
25.23
04-十月-24 15:59:59
15 分钟延时
股票
-0.40
-1.56%
今日范围
25.12 - 26.05
ISIN
N/A
来源
NASDAQ
-
BridgeBio Pharma Reports Second Quarter 2023 Financial Results and Business Update
03 8月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
18 7月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
17 7月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
14 7月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
12 7月 2023 16:31:00 条件 Nasdaq GlobeNewswire
-
20 6月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
13 6月 2023 09:33:35 条件 Nasdaq GlobeNewswire
-
15 5月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11 5月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports First Quarter 2023 Financial Results and Business Update
04 5月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference
27 4月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11 4月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
07 4月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
23 3月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
21 3月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Announces Pricing of Public Offering of Common Stock
08 3月 2023 07:00:01 条件 Nasdaq GlobeNewswire